Screener
Ameresco AMRC Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Ameresco in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests.
The source filing: Ameresco’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:42 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030169
| Line item | Redeemable Non-controlling Interests | Class A Common Stock / Shares | Class A Common Stock / Amount | Class B Common Stock / Shares | Class B Common Stock / Amount | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Treasury Stock / Shares | Treasury Stock / Amount | Non-controlling Interests | Total Stockholders’ Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based compensation expense | — | — | — | — | — | 4,176 | — | — | — | — | — | 4,176 |
| Restricted stock units released | — | 37,344 | — | — | — | — | — | — | — | — | — | — |
| Unrealized gain from interest rate hedges, net | — | — | — | — | — | — | — | 53 | — | — | — | 53 |
| Foreign currency translation adjustment | — | — | — | — | — | — | — | (1,917) | — | — | 25 | (1,892) |
| Accretion of tax equity financing fees | 46 | — | — | — | — | — | (46) | — | — | — | — | (46) |
| Distributions to NCI | — | — | — | — | — | — | — | — | — | — | (1,210) | (1,210) |
| Net (loss) income | — | — | — | — | — | — | (18,283) | — | — | — | 3,900 | (14,383) |
| Balance, March 31, 2026 | $1,465 | 34,939,417 | $3 | 18,000,000 | $2 | $400,287 | $678,408 | $(2,324) | 2,101,835 | $(11,788) | $45,381 | $1,109,969 |
Item 1. Condensed Consolidated Financial Statements
FAQ
- What is Ameresco's redeemable NCI?
- Ameresco (AMRC) reported redeemable NCI of $1.47M in Q1 2026.
- How has Ameresco's redeemable NCI changed year-over-year?
- Ameresco's redeemable NCI decreased by 25.5% year-over-year, from $1.97M to $1.47M.
- What is the long-term trend for Ameresco's redeemable NCI?
- Over 5 years (2020 to 2025), Ameresco's redeemable NCI has grown at a -48.4% compound annual growth rate (CAGR), from $38.85M to $1.42M.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.
Ask your AI about Ameresco's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude